| Road traffic accidents and psychotropic medication use in the Netherlands: A case-control study. | |
| | |
MedLine Citation:
|
PMID: 21501214 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
"WHAT THIS PAPER ADDS" statement What is already known about this subject • Some psychotropic medications (e.g. benzodiazepines, sedative antidepressants, etc.) can impair cognitive and psychomotor functions, and, therefore, endanger traffic safety. • There is a lack of knowledge concerning the role in traffic safety of first and new generations of psychotropic medications, new and chronic users, young and old drivers, and polypharmacy. What this study adds • There is an increased risk of having a traffic accident after being exposed to some psychotropic medicine classes, and, in particular, to SSRIs. • Health care professionals and patients should be properly informed about the potential effects of some psychoactive medications on driving abilities. • The role of SSRIs in traffic safety has to be further investigated. ABSTRACT: AIM: To examine the association between the use of commonly prescribed psychotropic medications and road traffic accident risk. METHODS: A record-linkage database was used to perform a case-control study, in the Netherlands. The data came from three sources: pharmacy prescription data, police traffic accident data, and driving license data. Cases were defined as drivers, who had a traffic accident that required medical assistance, between 2000 and 2007. Controls were defined as adults, who had a driving license and had no traffic accident during the study period. Four controls were matched for each case. The following psychotropic medicine groups were examined: antipsychotics, anxiolytics, hypnotics and sedatives, and antidepressants stratified in the two groups SSRIs and other antidepressants. Various variables, such as age, sex, medicine half-life, alcohol use were considered for the analysis. RESULTS: 3963 cases and 18828 controls were included in the case-control analysis. A significant association was found between traffic accident risk and exposure to anxiolytics [OR = 1.54 (95% CI: 1.11 - 2.15)], and SSRIs [OR = 2.03 (95% CI: 1.31 - 3.14)]. A statistically significant increased risk was also seen in chronic - anxiolytic users, females and young users (18 to 29 years old), chronic - SSRI users, females and middle-aged users (30 to 59 years old), and intermediate half-life hypnotic users. CONCLUSIONS: The results of this study support previous findings and confirm that psychoactive medications can constitute a problem in traffic safety. Both health care providers and patients should be properly informed of the potential risks associated with the use of these medicines. |
| | |
Authors:
|
S Ravera; N van Rein; J J de Gier; L T W de Jong-van den Berg |
Related Documents
:
|
8146444 - Effects of repeated challenges with exogenous oestradiol benzoate and progesterone on r... 3430124 - Mechanisms regulating the ovarian cycle in the frog rana cyanophlyctis: effect of unila... 15578604 - The contact toxicity of indoxacarb and five other insecticides to orius insidiosus (hem... 11482684 - Burn wound itch control using h1 and h2 antagonists. 15315544 - Interactive videoconferencing system for rural health education: a preliminary report. 6107734 - Personality and medical perception in benign myalgic encephalomyelitis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-18 |
Journal Detail:
|
Title: British journal of clinical pharmacology Volume: - ISSN: 1365-2125 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7503323 Medline TA: Br J Clin Pharmacol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society. |
Affiliation:
|
Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands Department of Pharmacoepidemiology and Pharmacoeconomics, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands Professor of Pharmaceutical Care, Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands Professor of Pharmacoepidemiology, Department of Pharmacoepidemiology and Pharmacoeconomics, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Paediatric drug development: Are population models predictive of pharmacokinetics across paediatric ...
Next Document: Additional safety risk to exceptionally approved drugs in Europe?